In a move aligned with the Trump Administration’s initiative to protect “Americans safe from dangerous synthetic narcotics,” the U.S. Embassy in New Delhi announced that it has revoked and denied visas for select business executives and corporate leaders due to their involvement in “trafficking fentanyl precursors.”

In a statement issued on September 18, 2025, the Embassy noted that these actions were taken under sections 221(i), 212(a)(2)(C), and 214(b) of the Immigration and Nationality Act. As a result, the affected individuals and their immediate family members may be “ineligible for travel to the United States.” The Embassy also indicated that executives associated with companies known to have “trafficked fentanyl precursors” will face heightened scrutiny in future U.S. visa applications.

“The U.S. Embassy in New Delhi remains steadfast in its commitment to combating illicit drug trafficking.  Individuals and organizations involved in the illegal production and trafficking of drugs to the United States, along with their families, will face consequences that may include being denied access to the United States,” affirmed Chargé d’affaires Jorgan Andrews.

Andrews emphasized that halting the flow of fentanyl and its precursors into the United States is a top priority.

“We are grateful to our counterparts in the Government of India for their close cooperation to combat this shared challenge,” Andrews noted. “Only by working together will our two governments address this transnational threat and keep both our people safe from illicit drugs.”

The Chargé d’affaires also highlighted that the Trump Administration has taken significant steps to address the crisis through Executive Orders designed to secure U.S. borders, disrupt drug trafficking organizations, and require reforms in source countries supplying illicit drugs and precursor chemicals.

“Together, we will build a safer, healthier, stronger future for America and India,” Andrews said.

Related posts:

Strengthening the Partnership with India is Key to Tackling the Global Synthetic Drug Crisis President Trump Declares ‘National Emergency’ Over Illegal Drugs; Imposes Tariffs on Canada, Mexico, and China Is Canada, Like Punjab, Fighting a War Against Drugs? Canada Seizes U.S.-Origin Cocaine Amid Rising Border Smuggling and U.S. Pressure Over Fentanyl